Latest News and Press Releases

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an off-the-shelf cancer immunotherapy designed to induce...

RICHMOND, Ind., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Liberation Bioindustries announces its co-founders have assumed new roles in the company; originally Chief Executive Officer (CEO), Mark Warner is...

This high unmet need has drawn interest to novel mechanisms of action — including Propanc Biopharma’s pancreatic proenzyme formulation known as PRP.

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation...

-- Study Results Support the use of TellDx to Personalize Cancer Care Management – -- Clinical study published in Cancer Discovery -- ANDOVER, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- TellBio,...

MONTRÉAL, 14 janv. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV : LOVE) (OTCQX : LOVFF) (FRA : 8CB0), producteur verticalement...

Cannara qualified for OTCQX trading in the U.S. and will release its Q1 2026 financial results on January 26, 2026

Die Rezertifizierung markiert über ein Jahrzehnt Halal-Konformität und sichert wichtige Lieferketten für biopharmazeutische Wachstumsmärkte bis 2026 und darüber hinaus. MINNETONKA, Minnesota, Jan. ...

Ce renouvellement marque plus d’une décennie de conformité Halal, sécurisant les chaînes d’approvisionnement essentielles pour les marchés de croissance biopharmaceutiques jusqu’en 2026 et au-delà. ...

Nu-Tek BioSciences renews its Halal certification, marking over a decade of scientific and regulatory support of its biotech customers needs.